Technology NetworksIDO Pathway Products for Immunotherapy Drug ResearchTechnology NetworksEven though the first generation of immunotherapy treatments has led to some great results in previously untreatable cancer, such as melanoma, only about third of… Continue reading
Technology NetworksIDO Pathway Products for Immunotherapy Drug ResearchTechnology NetworksEven though the first generation of immunotherapy treatments has led to some great results in previously untreatable cancer, such as melanoma, only about third of… Continue reading
Technology NetworksIDO Pathway Products for Immunotherapy Drug ResearchTechnology NetworksEven though the first generation of immunotherapy treatments has led to some great results in previously untreatable cancer, such as melanoma, only about third of… Continue reading
|
Athersys Poised For Lucrative Stem Cell Stroke Partnership This Year
Seeking Alpha Over the last few months, several SA followers have requested an update on stem cell biotech, Athersys Inc. (NASDAQ:ATHX). Realistically, there really hadn’t been any significant developments worthy of an update over the first part of 2017. On May 9th … |
|
Asymmetrex Presents Adult Tissue Stem Cell Counting at the Alliance for Regenerative Medicine’s First Partnering …
Benzinga On May 23 in Washington, D.C., stem cell medicine biotechnology start-up Asymmetrex will present its new contract service for adult tissue stem cell counting applications to company representatives attending Cell & Gene Exchange 2017. CGX17, the first … |